copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
About the BioMaP-Consortium The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) supports the Biomedical Advanced Research and Development Authority (BARDA) and is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, developers of innovative
Pharmaceutical Countermeasures Infrastructure (PCI) BARDA launched the new BioMaP-Consortium in October 2023 The BioMaP-Consortium is focused on enhancing U S preparedness by creating fast and flexible partnerships with the commercial biopharmaceutical industry
Public Health Preparedness: HHS Should Plan for Medical Countermeasure . . . HHS does not have a sustainable source of funding for the new program model, and it has not yet developed detailed plans or budgets HHS officials said that, without sustained funding for BioMaP or a similar program, the agency would be unprepared to respond to the next pandemic
HHS Takes an Important Step to Form a . . . - Arnold Porter BARDA’s efforts to establish the BioMap-Consortium occur against a backdrop of a range of private and public sector efforts to strengthen domestic drug manufacturing and supply and to prevent, reduce, or mitigate drug shortages
About BARDA (Biomedical Advanced Research and Development Authority) Gary L Disbrow, Ph D is the Director of the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) in the U S Department of Health and Human Services (HHS)
Biopharmaceutical Manufacturing Preparedness Consortium - ATI . . . The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) supports the Biomedical Advanced Research and Development Authority (BARDA) and is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, developers of innovative
such prohibited source in any work related to a USG funded Project . . . Clearly demonstrate in their membership application that they are capable of making a contribution to BioMaP technical objectives and other relevant subjects, technology, and capability domains as may be required in order to fully support the needs of the U S Government;